Prophylaxis after HSCT with hydroxychloroquine sulfate 400 mg as a single dose (Pediatric dose: 6.5 mg/kg, not to exceed 400 mg) every three weeks since engraftment until the COVID-19 pandemic has lapsed, is recommended.